Could a single lens implant replace daily eye drops for glaucoma?
NCT ID NCT07154810
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 23 people who received a special lens implant that slowly releases a glaucoma drug (bimatoprost) during cataract surgery. Researchers want to see if it keeps eye pressure low and vision clear for up to 7 years. The goal is to learn whether this combination device can safely treat both cataracts and glaucoma long-term.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bimatoprost implant combined with a special intraocular lens
What this could lead to
If successful, this could show that a single implant can control eye pressure and improve vision for years, reducing the need for daily eye drops.
What could go wrong
This is a small, observational follow-up study with only 23 participants, so results may not apply to everyone. Long-term safety and effectiveness are still being checked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Oftalmológico Robles
Santa Rosa de Copán, 41101, Honduras